首页|cTnI、NT-proBNP检测在急性心源性胸痛筛查及预后中的应用

cTnI、NT-proBNP检测在急性心源性胸痛筛查及预后中的应用

扫码查看
目的:分析cTnI、NT-proBNP在急性心源性胸痛(CCP)筛查及预后评估中的应用价值。方法:187例急性胸痛患者,依据病因分为急性CCP组及急性NCCP组,分析CCP发生的危险因素以及血清cTnI、NT-proBNP对CCP预后的评估价值。结果:cTnI、NT-proBNP为急性CCP发生的独立危险因素(P<0。05);死亡组血清cTnI、NT-proBNP水平较存活组高(P<0。05);两者联合检测预测急性CCP预后的效能高于单一指标(P<0。05)。结论:血清cTnI、NT-proBNP是急性CCP发生的危险因素,两者联合检测预测预后的效能更高。
Application of cTnI and NT-proBNP in screening and prognosis of acute cardiogenic chest pain
Objective:To analyze the application value of cTnI and NT-proBNP in screening and prognosis evaluation of acute CCP.Methods:187 patients with acute chest pain were divided into acute CCP group and acute NCCP group according to the cause.The risk factors for CCP and the evaluation value of serum cTnI and NT-proBNP for the prognosis of CCP were analyzed.Results:cTnI and NT-proBNP were independent risk factors for acute CCP(P<0.05).Serum cTnI and NT-proBNP levels in the death group were higher than those in the survival group(P<0.05).Joint detection of the two was more efficient than each indicatorin predicting the prognosis of acute CCP(P<0.05).Conclusion:Serum cTnI and NT-proBNP are risk factors for acute CCP,and joint detection of the two is more efficient in predicting the prognosis.

Acute cardiogenic chest painCardiac troponin IN-terminal pro-B-type natriuretic peptideScreeningPrognosis evaluation

吴竞、宫立新、黄泽玉、李鹏

展开 >

安徽医科大学附属巢湖医院急诊科,安徽合肥 238000

急性心源性胸痛 肌钙蛋白I N末端B型脑钠肽 筛查 预后评估

2024

现代科学仪器
中国分析测试协会

现代科学仪器

CSTPCD
影响因子:0.329
ISSN:1003-8892
年,卷(期):2024.41(5)